Hexosaminidase A (Human Recombinant, SF9) refers to the recombinant form of the human Hexosaminidase A enzyme produced using the Sf9 insect cell expression system. Sf9 cells, derived from the fall armyworm (Spodoptera frugiperda), are commonly used in biotechnology for the production of recombinant proteins due to their high efficiency and ability to perform post-translational modifications similar to those in human cells .
The recombinant Hexosaminidase A enzyme produced in Sf9 cells retains the same structural and functional properties as the naturally occurring enzyme. It hydrolyzes the terminal N-acetyl-D-hexosamine residues in various glycoconjugates, including oligosaccharides, glycolipids, and mucopolysaccharides . This hydrolytic activity is essential for the breakdown and recycling of these complex molecules within lysosomes.
Hexosaminidase A is one of the two major isoenzymes of lysosomal β-N-acetyl hexosaminidase, the other being Hexosaminidase B (HexB). While HexA can hydrolyze both neutral and anionic substrates, HexB is more specific to neutral oligosaccharides . The unique ability of HexA to degrade GM2 gangliosides in the presence of the GM2 activator protein (GM2A) highlights its critical role in cellular metabolism .